FORBES J M & CO LLP - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 2 filers reported holding AXSOME THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
FORBES J M & CO LLP ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$268,378
+97138.4%
3,8400.0%0.04%
+2.9%
Q2 2023$276
+16.5%
3,8400.0%0.03%
+6.2%
Q1 2023$237
-19.9%
3,8400.0%0.03%
-25.6%
Q4 2022$296
-99.9%
3,8400.0%0.04%
+30.3%
Q2 2021$259,000
+19.4%
3,8400.0%0.03%
+10.0%
Q1 2021$217,000
-30.7%
3,8400.0%0.03%
-34.8%
Q4 2020$313,000
+14.7%
3,8400.0%0.05%
+4.5%
Q3 2020$273,000
-13.6%
3,8400.0%0.04%
-21.4%
Q2 2020$316,000
+39.8%
3,8400.0%0.06%
+12.0%
Q1 2020$226,000
-43.1%
3,8400.0%0.05%
-23.1%
Q4 2019$397,000
+663.5%
3,840
-74.5%
0.06%
+490.9%
Q3 2018$52,000
+8.3%
15,0660.0%0.01%0.0%
Q2 2018$48,000
+29.7%
15,0660.0%0.01%
+22.2%
Q1 2018$37,000
-56.0%
15,0660.0%0.01%
-52.6%
Q4 2017$84,000
+1.2%
15,0660.0%0.02%
-9.5%
Q3 2017$83,000
+1.2%
15,0660.0%0.02%0.0%
Q2 2017$82,000
+39.0%
15,0660.0%0.02%
+40.0%
Q1 2017$59,000
-41.6%
15,0660.0%0.02%
-46.4%
Q4 2016$101,000
-15.1%
15,0660.0%0.03%
-15.2%
Q3 2016$119,00015,0660.03%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,132,645$37,332,00032.86%
MORGAN JESS S & CO INC 113,430$3,739,0002.47%
Fairmount Funds Management LLC 187,598$6,183,0002.25%
IRIDIAN ASSET MANAGEMENT LLC/CT 1,423,653$46,924,0001.43%
WMS Partners, LLC 250,000$8,240,0001.21%
Beck Bode, LLC 102,127$3,366,0000.94%
RTW INVESTMENTS, LP 1,616,497$53,280,0000.80%
MPM BioImpact LLC 110,155$3,631,0000.56%
Endurant Capital Management LP 52,048$1,716,0000.39%
Bellevue Group AG 752,945$24,817,0000.25%
View complete list of AXSOME THERAPEUTICS INC shareholders